Re-appointment of Mr. Bharat Brijmohan Sharma as Managing Director of the Company for a further period of Three year effective from April 01, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ganga Pharmaceuticals has re-appointed Mr. Bharat Brijmohan Sharma (DIN: 00077026) as Managing Director for a further three-year term effective April 1, 2026. The re-appointment was approved by the Board on March 10, 2026, based on recommendations from the Nomination and Remuneration Committee and Audit Committee, and is subject to shareholder approval. Mr. Sharma has over 35 years of experience in the business and pharma industry, and his spouse Mrs. Srijna Sharma is a Whole-time Director on the board. He is not debarred from holding office by any SEBI or other authority order.
This is a routine continuity announcement with no change in leadership direction. Existing promoter-family management remains in place, which provides stability but no fresh strategic catalyst for the stock.